1、 ZHANG W,AZIBANI F,LIBHABER E,et al.The role of conventional echocardiographic parameters on detecting subclinical anthracycline therapy related cardiac dysfunction-The SATRACD study[J].Front Cardiovasc Med,2022(9):966230. ZHANG W,AZIBANI F,LIBHABER E,et al.The role of conventional echocardiographic parameters on detecting subclinical anthracycline therapy related cardiac dysfunction-The SATRACD study[J].Front Cardiovasc Med,2022(9):966230.
2、 TSAI H R,GJESDAL O,WETHAL T,et al.Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin’s lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy[J].Am J Cardiol,2011,107(3):472-477. TSAI H R,GJESDAL O,WETHAL T,et al.Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin’s lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy[J].Am J Cardiol,2011,107(3):472-477.
3、 CHEN J,CHENG C,FAN L,et al.Assessment of left heart dysfunction to predict doxorubicin cardiotoxicity in children with lymphoma[J].Front Pediatr,2023(11):1163664. CHEN J,CHENG C,FAN L,et al.Assessment of left heart dysfunction to predict doxorubicin cardiotoxicity in children with lymphoma[J].Front Pediatr,2023(11):1163664.
4、 ARAUJO-GUTIERREZ R,CHITTURI K R,XU J,et al.Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity[J].Cardiooncology,2021,7(1):4. ARAUJO-GUTIERREZ R,CHITTURI K R,XU J,et al.Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity[J].Cardiooncology,2021,7(1):4.
5、 BHAGAT A A,KALOGEROPOULOS A P,BAER L,et al.Biomarkers and strain echocardiography for the detection of subclinical cardiotoxicity in breast cancer patients receiving anthracyclines[J].J Pers Med,2023,13(12):1710. BHAGAT A A,KALOGEROPOULOS A P,BAER L,et al.Biomarkers and strain echocardiography for the detection of subclinical cardiotoxicity in breast cancer patients receiving anthracyclines[J].J Pers Med,2023,13(12):1710.
6、 MUGGEO P,SCICCHITANO P,MUGGEO V,et al.Assessment of cardiovascular function in childhood leukemia survivors:The role of the right heart[J].Children,2022,9(11):1731. MUGGEO P,SCICCHITANO P,MUGGEO V,et al.Assessment of cardiovascular function in childhood leukemia survivors:The role of the right heart[J].Children,2022,9(11):1731.
7、 CHAGANTI B T,NEGISHI K,OKAJIMA K.Role of myocardial strain imaging in cancer therapy-related cardiac dysfunction[J].Curr Cardiol Rep,2022,24(6):739-748. CHAGANTI B T,NEGISHI K,OKAJIMA K.Role of myocardial strain imaging in cancer therapy-related cardiac dysfunction[J].Curr Cardiol Rep,2022,24(6):739-748.
8、 ZHU M,CHEN H,FULATI Z,et al.The value of left ventricular strain-volume loops in predicting response to cardiac resynchronization therapy[J].Cardiovasc Ultrasound,2019,17(1):3. ZHU M,CHEN H,FULATI Z,et al.The value of left ventricular strain-volume loops in predicting response to cardiac resynchronization therapy[J].Cardiovasc Ultrasound,2019,17(1):3.
9、 LI V W,SO E K,WONG W H,et al.Myocardial deformation imaging by speckle-tracking echocardiography for assessment of cardiotoxicity in children during and after chemotherapy:A systematic review and meta-analysis[J].J Am Soc Echocardiogr,2022,35(6):629-656. LI V W,SO E K,WONG W H,et al.Myocardial deformation imaging by speckle-tracking echocardiography for assessment of cardiotoxicity in children during and after chemotherapy:A systematic review and meta-analysis[J].J Am Soc Echocardiogr,2022,35(6):629-656.
10、 OIKONOMOU E K,KOKKINIDIS D G,KAMPAKTSIS P N,et al.Assessment of prognostic value of left ventricular global longitudinal strain for early prediction of chemotherapy-induced cardiotoxicity:A systematic review and meta-analysis[J].JAMA Cardiol,2019,4(10):1007-1018. OIKONOMOU E K,KOKKINIDIS D G,KAMPAKTSIS P N,et al.Assessment of prognostic value of left ventricular global longitudinal strain for early prediction of chemotherapy-induced cardiotoxicity:A systematic review and meta-analysis[J].JAMA Cardiol,2019,4(10):1007-1018.
11、 THEETHA K P,KUMAR A,JAYARANGAIAH A,et al.Chemotherapy induced right ventricular cardiomyopathy;a systematic review and meta-analysis[J].Front Cardiovasc Med,2023(10):1103941. THEETHA K P,KUMAR A,JAYARANGAIAH A,et al.Chemotherapy induced right ventricular cardiomyopathy;a systematic review and meta-analysis[J].Front Cardiovasc Med,2023(10):1103941.
12、 梁梦婕,金怡,郑哲岚.超声二维斑点追踪技术在蒽环类化疗药物心脏毒性监测中的应用价值[J].中华医学超声杂志(电子版),2019,16(10):749-755. 梁梦婕,金怡,郑哲岚.超声二维斑点追踪技术在蒽环类化疗药物心脏毒性监测中的应用价值[J].中华医学超声杂志(电子版),2019,16(10):749-755.
13、 CARDINALE D,IACOPO F,CIPOLLA C M.Cardiotoxicity of anthracyclines[J].Front Cardiovasc Med,2020(7):26. CARDINALE D,IACOPO F,CIPOLLA C M.Cardiotoxicity of anthracyclines[J].Front Cardiovasc Med,2020(7):26.
14、 CHOW E J,LEGER K J,BHATT N S,et al.Paediatric cardio-oncology:Epidemiology,screening,prevention,and treatment[J].Cardiovasc Res,2019,115(5):922-934. CHOW E J,LEGER K J,BHATT N S,et al.Paediatric cardio-oncology:Epidemiology,screening,prevention,and treatment[J].Cardiovasc Res,2019,115(5):922-934.
15、 GALáN-ARRIOLA C,VILLENA-GUTIéRREZ R,HIGUERO-VERDEJO M I,et al.Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity[J].Cardiovasc Res,2021,117(4):1132-1143. GALáN-ARRIOLA C,VILLENA-GUTIéRREZ R,HIGUERO-VERDEJO M I,et al.Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity[J].Cardiovasc Res,2021,117(4):1132-1143.
16、 PLANA J C,GALDERISI M,BARAC A,et al.Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy:A report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J].J Am Soc Echocardiogr,2014,27(9):911-939. PLANA J C,GALDERISI M,BARAC A,et al.Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy:A report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J].J Am Soc Echocardiogr,2014,27(9):911-939.
17、 LAZAR D R,CAINAP S,MANIU D,et al.Anthracycline’s effects on heart rate variability in children with acute lymphoblastic leukemia:Early toxicity signs-pilot study[J].J Clin Med,2023,12(22):7052. LAZAR D R,CAINAP S,MANIU D,et al.Anthracycline’s effects on heart rate variability in children with acute lymphoblastic leukemia:Early toxicity signs-pilot study[J].J Clin Med,2023,12(22):7052.
18、 KIM H,KANG H J,PARK K D,et al.Risk factor analysis for secondary malignancy in dexrazoxane-treated pediatric cancer patients[J].Cancer Res Treat,2019,51(1):357-367. KIM H,KANG H J,PARK K D,et al.Risk factor analysis for secondary malignancy in dexrazoxane-treated pediatric cancer patients[J].Cancer Res Treat,2019,51(1):357-367.
19、 BHAGAT A,KLEINERMAN E S.Anthracycline-induced cardiotoxicity:Causes,mechanisms,and prevention[J].Adv Exp Med Biol,2020(1257):181-192. BHAGAT A,KLEINERMAN E S.Anthracycline-induced cardiotoxicity:Causes,mechanisms,and prevention[J].Adv Exp Med Biol,2020(1257):181-192.
20、 SáGI J C,EGYED B,KELEMEN A,et al.Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma[J].BMC Cancer,2018,18(1):704. SáGI J C,EGYED B,KELEMEN A,et al.Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma[J].BMC Cancer,2018,18(1):704.
